GO:0035469 determination of pancreatic left/right asymmetry: Developmental Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035469 describes the developmental process that establishes the asymmetric left-right position of the pancreas within the organism.
• Left-right asymmetry is initiated at the embryonic node, where cilia-driven fluid flow and signaling molecules such as Nodal, Lefty, and Pitx2 are activated.
• Key genes implicated in pancreatic left-right asymmetry include NODAL, PITX2, SOX17, CHRD, BICC1, and DAND5, which regulate laterality decisions in vertebrates.
• Disruption of left-right asymmetry can lead to heterotaxy syndromes and abnormal pancreatic positioning, with clinical consequences for organ function.
• Altered expression of Nodal correlates with reduced survival in pancreatic cancer, linking laterality pathways to disease.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the genetic control of pancreatic left-right asymmetry.
Description
Determination of pancreatic left/right asymmetry (GO:0035469) is a biological process that ensures the pancreas develops on the correct side of the body, a fundamental feature of vertebrate organogenesis. This process is part of the broader left-right (L-R) axis specification that occurs during early embryogenesis, where breaking of initial symmetry leads to asymmetric placement of internal organs, including the pancreas, heart, and gut. The pancreas normally develops on the right side of the embryo in humans and other vertebrates, and failure to establish this asymmetry can result in congenital anomalies such as heterotaxy and pancreatic malposition. Researchers study GO:0035469 to understand how embryonic signals are translated into stable anatomical asymmetry and how errors in this process contribute to disease. The process involves a conserved cascade of genes, including NODAL, LEFTY, PITX2, and BICC1, which are regulated by ciliary flow and post-transcriptional mechanisms. In zebrafish and mouse models, disruption of these genes leads to randomized or reversed pancreatic positioning, providing insights into human laterality defects. This article synthesizes current knowledge on the molecular players, regulatory mechanisms, and experimental approaches used to study pancreatic left/right asymmetry, with a focus on how CRISPR-based models can accelerate discovery in this field.
determination of pancreatic left/right asymmetry At A Glance
| GO ID | GO:0035469 |
|---|---|
| GO term | determination of pancreatic left/right asymmetry |
| Ontology | biological_process |
| Synonym | none |
| Major function | Establishment of the asymmetric left-right position of the pancreas during embryogenesis |
| Related processes | Left-right axis specification, nodal signaling, ciliary flow, organ laterality |
| Key genes | NODAL, PITX2, SOX17, CHRD, BICC1, DAND5, LEFTY |
| Associated diseases | Heterotaxy syndromes, pancreatic malposition, pancreatic cancer |
| Model organisms | Zebrafish (Danio rerio), mouse, Xenopus |
What Is GO:0035469?
GO:0035469, determination of pancreatic left/right asymmetry, is defined as the developmental process that determines the asymmetric location of the pancreas with respect to the left and right halves of the organism. It encompasses the signaling events and gene regulatory networks that break initial symmetry and assign the pancreas to its correct side, typically the right side in humans.
Why Is determination of pancreatic left/right asymmetry Important in Cell Biology?
Understanding GO:0035469 is critical because defects in left-right asymmetry can cause severe congenital disorders, including heterotaxy and situs inversus, which affect multiple organs and can lead to life-threatening complications. The pancreas, in particular, relies on correct laterality for proper anatomical positioning and function, and misregulation of laterality genes such as NODAL has been linked to pancreatic cancer progression and poor patient survival. Studying this process also illuminates fundamental principles of embryonic patterning and ciliary biology that are conserved across vertebrates.
• Defects in left-right asymmetry cause heterotaxy syndromes, which can include pancreatic malposition and other organ anomalies.
• Correct pancreatic laterality is essential for normal organ function and digestive physiology.
• NODAL expression is increased in pancreatic cancer and correlates with reduced patient survival.
• Genes controlling laterality, such as PITX2 and SOX17, are also implicated in organ development and disease.
• Ciliary function and fluid flow at the embryonic node are critical for initiating asymmetry, linking ciliopathies to laterality defects.
• Post-transcriptional regulation by BICC1 and m6A methylation modulates DAND5 and left-right determinants.
• Zebrafish models provide rapid and transparent readouts of pancreatic asymmetry, facilitating genetic screens.
• CRISPR-based editing enables precise functional interrogation of laterality genes in model organisms and cell lines.
• Understanding laterality pathways may reveal therapeutic targets for pancreatic cancer and congenital anomalies.
• Research on GO:0035469 informs regenerative medicine efforts to engineer functional pancreatic tissue with correct orientation.
What Happens During determination of pancreatic left/right asymmetry?
Symmetry Breaking at the Embryonic Node
In simple terms: The embryo first needs to decide which side will be left and which will be right, and this starts at a tiny structure called the node.
In vertebrates, left-right asymmetry is initiated at the embryonic node, a transient structure lined with motile cilia that generate a leftward fluid flow. This flow is thought to transport signaling molecules or trigger mechanosensory responses that activate asymmetric gene expression. In zebrafish, the equivalent structure is Kupffer's vesicle, where cilia-driven flow is essential for laterality determination. Disruption of ciliary function or flow leads to randomized organ positioning, including the pancreas.
Nodal Signaling Cascade and Left-Side Gene Activation
In simple terms: Once the left side is defined, a chain of molecular signals turns on genes that tell the left side to become 'left'.
The leftward flow triggers asymmetric expression of NODAL, a TGF-beta superfamily ligand, on the left side of the embryo. NODAL activates its target genes, including LEFTY and PITX2, which reinforce left-sided identity and repress right-sided programs. PITX2 is a homeobox transcription factor that serves as a key effector of left-sided identity in multiple organs, including the pancreas. In zebrafish, Pegasus (an Ikaros family member) regulates pitx2 expression and influences left-right asymmetry.
Role of BICC1 and DAND5 in Modulating Nodal Signaling
In simple terms: Some molecules act as brakes or modulators to ensure the left-side signals are correctly timed and placed.
BICC1 is an RNA-binding protein that regulates the stability and localization of DAND5 mRNA, a Nodal inhibitor. m6A methylation of the Dand5 3'UTR inhibits recruitment to Bicc1, thereby affecting DAND5 expression and downstream Nodal signaling. This post-transcriptional layer of regulation ensures precise control of left-right asymmetry. Disruption of Bicc1 or Dand5 leads to laterality defects in model organisms.
Pancreatic Bud Positioning and Organ Laterality
In simple terms: The pancreas starts as a small bud that must grow on the correct side of the gut tube.
The pancreas develops from dorsal and ventral buds that evaginate from the foregut endoderm. In humans, the ventral bud rotates and fuses with the dorsal bud to form the definitive pancreas, and this rotation is influenced by left-right asymmetry cues. Sonic hedgehog (Shh) signaling plays a versatile role in gut development, including pancreatic bud formation and positioning. Perturbations in laterality genes can lead to abnormal pancreatic positioning, such as annular pancreas or pancreatic heterotopia.
Integration with Gut and Heart Laterality
In simple terms: The pancreas does not decide its side alone; it coordinates with the heart and gut to ensure all organs are correctly placed.
Left-right asymmetry is a global process that coordinates the positioning of multiple organs, including the heart, lungs, stomach, and pancreas. The same Nodal-Pitx2 cascade operates in various organ primordia, and mutations in laterality genes often cause combined defects (heterotaxy). In zebrafish, selection for behavioral lateralization correlates with anatomical left-right asymmetries, suggesting integration across systems. Thus, pancreatic asymmetry is best understood in the context of whole-embryo laterality.
Key Genes Involved in GO:0035469 determination of pancreatic left/right asymmetry
The following genes and proteins have been experimentally implicated in the determination of pancreatic left/right asymmetry or in the broader left-right patterning that affects pancreatic positioning.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NODAL | TGF-beta ligand that initiates left-sided signaling | Central to left-right asymmetry; increased expression linked to pancreatic cancer |
| PITX2 | Homeobox transcription factor; effector of left-sided identity | Regulated by Pegasus; key marker of laterality |
| SOX17 | Transcription factor required for Kupffer's vesicle formation | Essential for left-right asymmetry in zebrafish |
| CHRD | Chordin; BMP antagonist involved in node formation | Required for Kupffer's vesicle and laterality |
| BICC1 | RNA-binding protein regulating DAND5 mRNA | Modulates Nodal signaling via m6A-dependent mechanism |
| DAND5 | Nodal inhibitor; its 3'UTR is regulated by BICC1 | Post-transcriptional control of laterality |
| LEFTY | Nodal antagonist; reinforces left-sided signaling | Downstream target of Nodal in laterality cascade |
| SHH | Sonic hedgehog; roles in gut and pancreatic development | Influences pancreatic bud positioning |
| PEGASUS | Ikaros family transcription factor | Regulates pitx2 expression and left-right asymmetry |
| FOXJ1 | Forkhead transcription factor; ciliogenesis regulator | Cilia-driven flow at the node is critical for laterality |
| KIF3A | Kinesin motor protein; intraflagellar transport | Required for nodal cilia function and asymmetry |
| PKD2 | Polycystin-2; calcium channel in cilia | Mechanosensation of nodal flow |
| ZIC3 | Zinc finger transcription factor | Mutations cause heterotaxy in humans |
| ACVR2B | Activin receptor; Nodal signaling component | Laterality defects in model organisms |
| GDF1 | TGF-beta ligand; Nodal co-factor | Required for left-right patterning |
| CFC1 | Cryptic; EGF-CFC co-receptor for Nodal | Essential for Nodal signaling and laterality |
| MED12 | Mediator complex subunit | Regulates Nodal signaling and laterality |
How Is determination of pancreatic left/right asymmetry Regulated?
The determination of pancreatic left/right asymmetry is regulated at multiple levels. At the transcriptional level, NODAL and its targets PITX2 and LEFTY are controlled by a self-activating and antagonistic network that ensures robust left-sided expression. Post-transcriptional regulation by BICC1 and m6A methylation modulates DAND5 mRNA stability and translation, thereby tuning Nodal signaling. Ciliary flow at the embryonic node provides a mechanical cue that initiates asymmetric gene expression, and defects in ciliary proteins disrupt this regulation. Additionally, signaling pathways such as Sonic hedgehog (Shh) influence pancreatic bud positioning and gut laterality. These layers of regulation ensure that pancreatic asymmetry is established reliably despite developmental noise.
determination of pancreatic left/right asymmetry and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NODAL | Pancreatic cancer progression; heterotaxy | Knockout and overexpression in pancreatic cancer cell lines; zebrafish laterality assays |
| PITX2 | Heterotaxy; laterality defects | CRISPR knockout in zebrafish; Pitx2 conditional KO in mouse |
| ZIC3 | Heterotaxy, congenital heart defects | Patient-derived iPSCs with point mutations; zebrafish zic3 KO |
| BICC1 | Laterality defects; renal ciliopathy | Bicc1 KO mouse; m6A site knock-in in Dand5 3'UTR |
| SOX17 | Laterality defects; Kupffer's vesicle malformation | Zebrafish sox17 knockout; rescue with wild-type mRNA |
Heterotaxy and Congenital Laterality Defects
Heterotaxy syndromes arise from failures in left-right asymmetry determination and can include abnormal pancreatic positioning, such as situs inversus or ambiguous laterality. Patients with heterotaxy often have complex congenital heart defects and other organ anomalies, and pancreatic involvement can lead to digestive complications. Mutations in laterality genes such as ZIC3, NODAL, and LEFTY have been identified in heterotaxy patients.
Pancreatic Cancer and NODAL Signaling
Increased expression of NODAL correlates with reduced patient survival in pancreatic cancer, suggesting that reactivation of embryonic laterality pathways contributes to tumor progression. NODAL signaling promotes cell proliferation, invasion, and stemness in cancer cells, and its overexpression is observed in various malignancies. Targeting NODAL or its downstream effectors may offer therapeutic opportunities in pancreatic cancer.
Ciliopathies and Pancreatic Asymmetry
Ciliopathies, such as primary ciliary dyskinesia and Bardet-Biedl syndrome, often involve defects in left-right asymmetry due to impaired nodal cilia function. These conditions can present with pancreatic malposition or other organ laterality defects. Studying ciliary genes in model organisms has elucidated the mechanistic link between cilia and pancreatic asymmetry.
From determination of pancreatic left/right asymmetry-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NODAL abolish pancreatic left/right asymmetry? | CRISPR knockout of NODAL in zebrafish or mouse embryos, followed by in situ hybridization for pancreatic markers |
| How does m6A methylation of Dand5 3'UTR affect Bicc1 binding? | Point mutations in the m6A consensus motif of Dand5 3'UTR using CRISPR knock-in in cell lines, followed by RNA immunoprecipitation |
| Can overexpression of PITX2 rescue laterality defects in Pegasus mutants? | Transgenic overexpression of pitx2 in zebrafish pegasus mutants |
| What is the role of SOX17 in Kupffer's vesicle formation? | CRISPR knockout of sox17 in zebrafish, combined with high-speed imaging of cilia |
| Does Chordin regulate pancreatic bud positioning via BMP antagonism? | Conditional knockout of Chrd in mouse pancreatic progenitors; lineage tracing |
| Can CRISPR activation of NODAL in pancreatic cancer cells mimic laterality pathway reactivation? | dCas9-VP64 overexpression system in pancreatic cancer cell lines, followed by RNA-seq |
How to Study the determination of pancreatic left/right asymmetry Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR-Cas9 knockout | Gene function loss | Generating zebrafish or mouse lines with laterality defects |
| CRISPR knock-in | Precise point mutations or tags | Modeling human variants in BICC1 or DAND5 |
| RNA-seq | Transcriptome-wide gene expression | Identifying asymmetric genes in mutants |
| MeRIP-seq | m6A methylation sites | Mapping Dand5 3'UTR methylation |
| In situ hybridization | Spatial gene expression | Visualizing pancreatic markers in embryos |
| High-speed video microscopy | Ciliary beating and fluid flow | Quantifying leftward flow in Kupffer's vesicle |
| Immunofluorescence | Protein localization and organ position | Assessing pancreatic laterality in whole mounts |
| CRISPR library screening | Pooled gene function | Discovering novel laterality regulators |
Genetic Knockout and Knock-in in Zebrafish
Zebrafish are an excellent model for studying pancreatic left/right asymmetry due to their external development and transparent embryos. CRISPR-Cas9 can be used to generate knockout lines for genes such as sox17, chrd, and bicc1, and knock-in of point mutations can model human variants. Phenotypes are assessed by in situ hybridization for pancreatic markers (e.g., insulin, trypsin) and by imaging of Kupffer's vesicle cilia.
Transcriptomic and Epitranscriptomic Profiling
RNA-seq and m6A-seq can identify asymmetric gene expression and post-transcriptional modifications in laterality mutants. For example, m6A methylation of Dand5 3'UTR can be mapped by MeRIP-seq, and its effect on Bicc1 binding can be tested by RNA pull-down. These methods reveal regulatory layers beyond transcription.
Imaging of Ciliary Flow and Organ Position
High-speed video microscopy of nodal cilia and fluorescent bead tracking can quantify leftward flow in zebrafish Kupffer's vesicle. Whole-mount immunofluorescence for pancreatic markers allows visualization of organ position relative to the midline. These imaging techniques are critical for linking molecular defects to anatomical outcomes.
CRISPR Library Screening for Laterality Genes
Pooled CRISPR knockout libraries can be screened in zebrafish or cell models to identify novel regulators of pancreatic asymmetry. Bioinformatics analysis of screening data can prioritize candidate genes for functional validation. This approach enables unbiased discovery of laterality pathways.
How CRISPR Can Be Used to Study GO:0035469 determination of pancreatic left/right asymmetry
Knockout
CRISPR knockout is used to completely ablate genes such as NODAL, PITX2, or SOX17 to assess their requirement for pancreatic left/right asymmetry. In zebrafish, F0 crispants or stable mutant lines can be generated rapidly, and pancreatic positioning is scored by in situ hybridization. In mouse, conditional knockout allows tissue-specific deletion to avoid early lethality.
Point Mutation
Point mutations can be introduced via CRISPR homology-directed repair to model human variants or to disrupt specific regulatory elements, such as the m6A site in the Dand5 3'UTR. These models help dissect the precise molecular mechanisms by which individual nucleotides affect Bicc1 binding and Nodal signaling.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci allows real-time visualization of protein localization and dynamics during laterality determination. For example, tagging PITX2 with GFP enables tracking of its asymmetric expression in live embryos.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can drive ectopic expression of laterality genes such as NODAL or PITX2 to test sufficiency for pancreatic asymmetry. Overexpression of NODAL in pancreatic cancer cells can mimic reactivation of embryonic pathways and assess oncogenic effects.
How EDITGENE Supports determination of pancreatic left/right asymmetry Research
Researchers studying determination of pancreatic left/right asymmetry-related genes often need to determine whether a candidate gene is causally involved in laterality decisions or whether its manipulation can rescue or induce asymmetry defects. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such functional studies, from generating knockout models to precise point mutations and overexpression systems.
Contact EDITGENE today to design your custom CRISPR model for determination of pancreatic left/right asymmetry research.
Frequently Asked Questions About determination of pancreatic left/right asymmetry
What is determination of pancreatic left/right asymmetry?
It is the developmental process (GO:0035469) that establishes the asymmetric left-right position of the pancreas within the organism, ensuring it develops on the correct side.
What genes are involved in pancreatic left/right asymmetry?
Key genes include NODAL, PITX2, SOX17, CHRD, BICC1, DAND5, LEFTY, and SHH, which regulate symmetry breaking and organ positioning.
How is left/right asymmetry determined in embryos?
It is initiated by cilia-driven fluid flow at the embryonic node, which triggers asymmetric expression of NODAL and downstream targets like PITX2.
What happens if pancreatic left/right asymmetry goes wrong?
Defects can lead to heterotaxy syndromes, situs inversus, and abnormal pancreatic positioning, often with other organ anomalies.
Is pancreatic left/right asymmetry related to cancer?
Yes, increased NODAL expression correlates with reduced survival in pancreatic cancer, suggesting reactivation of laterality pathways in tumors.
What model organisms are used to study pancreatic asymmetry?
Zebrafish, mouse, and Xenopus are commonly used, with zebrafish offering rapid genetic manipulation and transparent embryos.
How does BICC1 regulate left/right asymmetry?
BICC1 binds DAND5 mRNA and regulates its stability; m6A methylation of the Dand5 3'UTR inhibits this binding, affecting Nodal signaling.
What is the role of PITX2 in laterality?
PITX2 is a transcription factor that acts as a key effector of left-sided identity and is regulated by upstream factors like Pegasus.
Can CRISPR be used to study pancreatic left/right asymmetry?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise functional interrogation of laterality genes in various organisms.
What are heterotaxy syndromes?
Heterotaxy refers to abnormal arrangement of internal organs due to defects in left-right asymmetry, often involving the heart, gut, and pancreas.
Conclusion
Determination of pancreatic left/right asymmetry (GO:0035469) is a fundamental developmental process that ensures the pancreas is correctly positioned along the left-right axis. It relies on a conserved cascade of genes, including NODAL, PITX2, and BICC1, and is regulated by ciliary flow and post-transcriptional mechanisms. Defects in this process cause heterotaxy syndromes and are linked to pancreatic cancer progression. Advances in CRISPR-based genome editing and screening are accelerating the discovery of new laterality regulators and providing models to test causality. EDITGENE offers a full suite of services to support this research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Rothé B et al.. 2025. m(6)A methylation inhibits recruitment of the Dand5 3'UTR to the left-right determinant Bicc1.. RNA 31(10):1379-1390 PMID: 40634109
- 2. Aamar E et al.. 2010. Sox17 and chordin are required for formation of Kupffer's vesicle and left-right asymmetry determination in zebrafish.. Dev Dyn 239(11):2980-8 PMID: 20925124
- 3. Aylsworth AS. 2001. Clinical aspects of defects in the determination of laterality.. Am J Med Genet 101(4):345-55 PMID: 11471158
- 4. Yost HJ. 1998. Left-right development from embryos to brains.. Dev Genet 23(3):159-63 PMID: 9842710
- 5. John LB et al.. 2013. Pegasus, the 'atypical' Ikaros family member, influences left-right asymmetry and regulates pitx2 expression.. Dev Biol 377(1):46-54 PMID: 23499657
- 6. Fukuda K et al.. 2002. Versatile roles for sonic hedgehog in gut development.. J Gastroenterol 37(4):239-46 PMID: 11993506
- 7. Facchin L et al.. 2009. Lines of Danio rerio selected for opposite behavioural lateralization show differences in anatomical left-right asymmetries.. Behav Brain Res 197(1):157-65 PMID: 18801388
- 8. Kong B et al.. 2015. Increased expression of Nodal correlates with reduced patient survival in pancreatic cancer.. Pancreatology 15(2):156-61 PMID: 25708930
